Currently the gold standard test to diagnose steatorrhea remains the 72 hour fat balance method, which is based on the premise that fat intake minus fat output equals fat absorbed (2) . A coefficient of fat absorption, calculated from the intake/output data, is the standard value used to indicate malabsorption. This test is very time consuming and logistically difficult as it requires a three to five day stool collection and a complete dietary intake record. Additionally, most patients with fat malabsorption have diarrhea and therefore accurate and complete collection is difficult, particularly in infants and children. These limitations make the 72 hour fat balance method impractical in the clinical setting and stress the need for a facile, accurate test of fat malabsorption.
Despite previous attempts to develop simpler methods than the 72 hour fat balance method, none have proven to be easier than and as reliable as the gold standard. and 100% (unpublished results). These results suggested that the fecal behenate method was quite robust in control participants and indicate that the method might be quite useful for differentiating normal vs. excessive fecal fat loss. Those studies encouraged us to pursue the current investigations in CF patients.
The current study was designed to test the hypothesis that the ratio of stool lauric:behenic acid would be predictive of the coefficient of fat absorption using the 72 hour fat balance method in children and adults with cystic fibrosis (CF) when they were not taking their customary pancreatic enzyme supplements and when taking enzyme supplements before or throughout the meal. Center at CCHMC and The Children's Hospital.
MATERIALS AND METHODS

Patient Population
Experimental Methods:
The study design was a cross-over, whereby one group of participants was initially on PERT and then repeated the study off PERT, and the other group was initially off PERT and then on PERT. The independent variables analyzed were percent fat absorption assessed by the lauric acid/behenic acid and 72-hour fat balance method, both continuous variables. The primary dependent variable in this study is fat malabsorption status. Participants were randomized to 3 days without pancreatic enzyme supplements or their usual supplements administered before meals. It was anticipated that most participants would be taking PERT prior to meals and not throughout; however, this was noted specifically as it was relevant to the studies.
Participants were encouraged to select a high-fat (at least 70g fat/day) diet, and a The fat content of all food consumed was calculated to obtain total fat intake for each participant. At the end of the 72-hour collection, all stools were pooled and analysis performed using nuclear magnetic resonance (5, 6) by Mayo Clinic Laboratories (Rochester, MN). All results were expressed as the coefficient of fat absorption:
Coefficient of fat absorption (CFA)% = dietary fat intake -fecal fat output x 100% dietary fat intake Subsequently, participants either used their standard pancreatic enzyme supplements or no supplements for 3 days as outlined above in preparation for the 2 nd study period. Participants then repeated the study using their pancreatic enzyme supplements throughout the duration of the meal for the 3 rd study period (enzymes would be administered equally at the beginning, middle, and end of the meal).
Statistical Considerations
a. Sample Size Calculation: The sample size was based on comparison of the methods when participants were either receiving or not receiving PERT. The expectation is that when the participants are on PERT, the amount of fat absorption would be 85%, as compared to 60% when they are not receiving supplements. Thus, the reduction in one group is 25% and in the other group it is -25%. The standard deviation is not known, so to be conservative a SD equal to 20% was used. Using the sample size procedure for a two-sample t-test, the n required was computed. The software used was nQuery®, version 5.0 for a two-sided t-test with a level of significance of 0.05 and a power of 80%. For this aim (Aim 1), 9 individuals crossed over would be sufficient. The assessment of differences between PERT during meals vs before meals was considered exploratory and therefore a pilot study (Aim 2). It was anticipated that the sample size selected for Aim 1 might not be sufficient to determine the impact of using PERT before vs. during the meal. Comparisons of fat absorption by the behenate method vs. the 72 hour fat balance method across all conditions were made using the Pearson Correlation coefficient.
RESULTS
Eighteen participants met inclusion criteria and were enrolled in the study.
Fifteen participants completed at least 2 of the arms of the study. Fourteen participants completed all 3 arms and one did not complete the arm in which PERT was consumed throughout the meal. Participants were age 8-50 years with a mean age of 21.1 years and a median age of 19.5 years. There were 7 males and all were Caucasian.
Participants were well nourished with a body mass index (BMI) in adults (greater than There was a trend toward concurrence for the 2 methods (Figure 3 ). For all studies performed for the 3 arms of the study, there was a significant correlation between the fat absorption assessed by the 72 hour fat balance method compared to fecal behenate method (r 2 =0.219, p=0.001). We assessed fat absorption during periods when participants were not on PERT compared to when they were taking PERT either before or during meals. For the fecal behenate method, fat absorption was 51.7±21.6%
without PERT compared to 64.5±28.3% taking PERT before meals and 67.6±21.1%
during meals. When we compared fat absorption by the 72 hour fat balance method for all participants completing all 3 arms of the study, we found fat absorption of 51.5±22.7% without PERT compared to 80.4±18.4% with PERT before meals and 78.3±15.7% during meals. There was no significant difference (p=ns) in fat absorption when PERT was administered before or during meal consumption (Figure 4 ) for either method.
DISCUSSION
The results of the current study showed that the fecal behenate method which measures fecal lauric acid/behenic acid ratio after a test meal containing lauric acid mixed with other fatty acids, correlates with the "gold standard", the 72 hour quantitative fecal fat measurement. Unfortunately, the correlation is not sufficiently robust that we could confidently suggest that the behenate method could replace the 72 hour fat balance method for the management of pancreatic enzyme treatment of patients with cystic fibrosis. In our preliminary studies, fat absorption does not appear to be impacted by whether enzymes are taken preceding or during the meal in cystic fibrosis. To definitively answer this question an extremely large sample (n=329 with 80% power and alpha of 0.05) would have to be studied to definitively indicate that there are differences in absorption resulting from the timing of enzyme administration.
The goal of this study was to determine if we could find a facile way to estimate fat absorption in patients with cystic fibrosis that could be used to monitor responses to interventions directed at correcting fat absorption. Given the complications that can result from fat malabsorption, accurate and timely identification is critical in the diagnosis and management of these patients. Although other tests of fat malabsorption have been proposed, these tests are limited in application, accuracy and feasibility.
Several other diagnostic tests to identify fat malabsorption have been proposed. In
1961, Drummey et al. reintroduced the technique of microscopic examination of stool for
fat globules and outlined a scale for grading this steatorrhea (7) . Although the sensitivity of this method has been reported as high as 96% (8), these results have not been reproducible (9, 10) . Additionally, this test is only a semiquantitative measure with relatively poor specificity (11), thus patients with fat malabsorption identified by this method still need a 72-hour fat balance study to quantify and confirm this steatorrhea. making it ideal for use in the pediatric population (14) . This procedure was modified by
Tran et al., who found that acidification of the stool prior to performing the steatocrit improved the fat separation and increased the sensitivity of this method (15, 16) .
Unfortunately, the two initial studies by Tran et al. using this method were quite small and larger studies using the acid steatocrit have not been as promising, with a lower sensitivity (17) and a weak correlation between the acid steatocrit and the 72 hour fatbalance method (18) . Recently, work using dysprosium chloride as a nonabsorbable marker with stably-labeled triglycerides as a method to assess fat absorption has been reported (19) . This work has demonstrated that a single marked stool with brilliant blue in which the fractional excretion of a non-absorbable marker, dysprosium, is assessed can be compared to the presence of a labeled fatty acid. A high correlation was demonstrated between the fractional excretion of Dy and 13(C) in stool indicating that this was a promising method to assess fat absorption on a single marked stool.
Unfortunately, the measurement of Dy and 13(C) require mass spectrometry, which is not routinely available, and material costs are expensive.
There are little data examining the effects of timing of pancreatic enzyme supplementation in relationship to meals. There is anecdotal evidence that administering enzyme supplements during the meal rather than before the meal may 1) Absorption from a single meal, on which the fecal behenate method is based, may not be representative of the average fat absorption over the 3 day period over which the 72 hour fat balance method is based. There are little data on meal-to-meal and day-today variation in fat excretion in normal or diseased humans even though assays for fecal fat have been reported for over a century (20) . Early work on fat absorption does suggest there is day-to-day variation in fat excretion in adults with jaundice reported secondary to cirrhosis or hepatitis (21 
